Warning: Cannot modify header information - headers already sent by (output started at /home/heffter/heffter.org/news/index.php:2) in /home/heffter/heffter.org/news/wp-includes/feed-rss2.php on line 8
HRI News http://www.heffter.org/news Fri, 10 Apr 2015 22:18:07 +0000 en-US hourly 1 http://wordpress.org/?v=4.1.1 Psychedelic drugs “as safe as riding a bike” | The Independent http://www.heffter.org/news/psychedelic-drugs-as-safe-as-riding-a-bike-the-independent/ http://www.heffter.org/news/psychedelic-drugs-as-safe-as-riding-a-bike-the-independent/#comments Fri, 10 Apr 2015 22:14:54 +0000 http://www.heffter.org/news/?p=309 A feature article in The Independent profiles a Norwegian married couple and their goal of providing access to quality psychedelics. Clinical psychologist Pål-Ørjan Johansen and his wife Teri Kreb, a research fellow in the Department of Neuroscience at the Norway University of Science and Technology, aim to reform drug policy in the interest of scientific research and human rights. They established a non-profit foundation, EmmaSofia, to manufacture pharmaceutical-grade MDMA and psilocybin.

“Speaking on the website of the organisation the couple founded, Johansen, who has experience in providing treatments for anxiety disorders said: ‘Psychedelics often produce profound experiences while at the same time having a safety risk profile comparable to many activities of daily life, such as riding a bike or playing soccer.’

“Johansen says that through the use of MDMA and magic mushrooms he was able to treat his own alcohol addiction and, in an interview with Newsweek, highlights a study in the American Journal of Psychiatry which supports the idea that psychedelics could be useful in the treatment of heroin addiction.”

Psychedelic drugs “as safe as riding a bike or playing soccer” and could help solve addiction | The Independent


http://www.heffter.org/news/psychedelic-drugs-as-safe-as-riding-a-bike-the-independent/feed/ 0
Purdue Exponent highlights work by Heffter President http://www.heffter.org/news/purdue-exponent-highlights-work-by-heffter-president/ http://www.heffter.org/news/purdue-exponent-highlights-work-by-heffter-president/#comments Sat, 14 Mar 2015 21:11:29 +0000 http://www.heffter.org/news/?p=305 The Purdue Exponent, the daily student newspaper of Purdue University, has a feature article on the work of David Nichols, the co-founder and President of the Heffter Research Institute. Staff writer Danielle Wilkinson covers Dr. Nichols’ research on the psychedelic chemicals MDMA (“Ecstasy”) and LSD.

“’We made LSD analogues and derivatives in an attempt to understand why LSD was so potent, and also how it might interact with brain receptors,’ said Nichols. ‘Then as my research evolved, we became more interested in how the various features of the drug molecules engaged different parts of the receptor.’

“He was able to obtain grants from the National Institute on Drug Abuse (NIDA) to study structural variations of the MDMA molecule by insisting that people who had interactions with the drug couldn’t be treated until they knew how the drugs affected the body.”

LSD and Ecstasy researched at Purdue produce amazing results | The Purdue Exponent

http://www.heffter.org/news/purdue-exponent-highlights-work-by-heffter-president/feed/ 0
Second part of special issue on psychedelics and addiction published by OPEN http://www.heffter.org/news/second-part-of-special-issue-on-psychedelics-and-addiction-published-by-open/ http://www.heffter.org/news/second-part-of-special-issue-on-psychedelics-and-addiction-published-by-open/#comments Wed, 25 Feb 2015 21:45:37 +0000 http://www.heffter.org/news/?p=289 The OPEN Foundation, a Dutch organization that supports psychedelic research, published the second part of a special issue in the journal Current Drug Abuse Reviews. Three new articles focus on the use of psychedelics for treating addiction, including an article on the Heffter-supported study on tobacco addiction at Johns Hopkins University. Other article topics include the potential of psychedelics in healthcare and a review of LSD in the treatment of addictions.

Second part of special issue compiled by OPEN published

http://www.heffter.org/news/second-part-of-special-issue-on-psychedelics-and-addiction-published-by-open/feed/ 0
Magic mushrooms and the healing trip | The New Yorker http://www.heffter.org/news/magic-mushrooms-and-the-healing-trip-the-new-yorker/ http://www.heffter.org/news/magic-mushrooms-and-the-healing-trip-the-new-yorker/#comments Wed, 18 Feb 2015 03:27:47 +0000 http://www.heffter.org/news/?p=243 The New Yorker magazine has a brief but powerful documentary video illustrating their recent article on psychedelic research. The video features cinematographer Eddie Marritz, one of the subjects in the Heffter-sponsored study on psilocybin therapy for cancer patients at New York University.

Magic Mushrooms and the Healing Trip | The New Yorker

http://www.heffter.org/news/magic-mushrooms-and-the-healing-trip-the-new-yorker/feed/ 0
Matthew Johnson: “Psychedelic therapy may become available in a decade” http://www.heffter.org/news/matthew-johnson-psychedelic-therapy-may-become-available-in-a-decade/ http://www.heffter.org/news/matthew-johnson-psychedelic-therapy-may-become-available-in-a-decade/#comments Wed, 18 Feb 2015 03:23:34 +0000 http://www.heffter.org/news/?p=241 In an interview on the website of the Open Foundation, Heffter researcher Matthew Johnson discusses many topics in the field of psychedelic science. Dr. Johnson talks with writer Olivier Taymans about his study on psilocybin as a treatment for tobacco addiction, the timeline for legalization of psychedelics for clinical applications, the nature of mystical experiences, advice for people seeking a career in psychedelic research, and other subjects.

Matthew Johnson: “Psychedelic therapy may become available in a decade” | The Open Foundation 

http://www.heffter.org/news/matthew-johnson-psychedelic-therapy-may-become-available-in-a-decade/feed/ 0
A New Understanding: The Science of Psilocybin | New York Open Center http://www.heffter.org/news/a-new-understanding-the-science-of-psilocybin-new-york-open-center/ http://www.heffter.org/news/a-new-understanding-the-science-of-psilocybin-new-york-open-center/#comments Wed, 18 Feb 2015 03:18:59 +0000 http://www.heffter.org/news/?p=238 On March 6th, the New York Open Center will host a showing of the documentary film A New Understanding: The Science of Psilocybin. Along with the film, the event features a panel discussion with Heffter researchers Stephen Ross, Jeffrey Guss, and Anthony Bossis.

A New Understanding: The Science of Psilocybin | New York Open Center

http://www.heffter.org/news/a-new-understanding-the-science-of-psilocybin-new-york-open-center/feed/ 0
Could a psychedelic drug prevent asthma? | Science World Report http://www.heffter.org/news/could-a-psychedelic-drug-present-asthma-science-world-report/ http://www.heffter.org/news/could-a-psychedelic-drug-present-asthma-science-world-report/#comments Wed, 18 Feb 2015 03:15:20 +0000 http://www.heffter.org/news/?p=236 Most contemporary research on psychedelic drugs focuses on the treatment of psychological disorders such as depression and PTSD. Now, researchers at LSU Health New Orleans School of Medicine are investigating the use of the psychedelic (R)-DOI to treat asthma, a disease that affects 25 million Americans.

According to Charles Nichols, Associate Professor of Pharmacology and Experimental Therapeutics, “Not only is this a significant breakthrough in the field of study of serotonin and psychiatric drugs, but it is a breakthrough in the field of asthma as well. We have identified an entirely new anti-inflammatory mechanism for the treatment of asthma in the clinic that could someday be administered in an inhaler or a daily pill.”

Could a Psychedelic Drug Prevent Asthma? | Science World Report

http://www.heffter.org/news/could-a-psychedelic-drug-present-asthma-science-world-report/feed/ 0
The government should support psychedelic research | THE WEEK http://www.heffter.org/news/the-government-should-support-psychedelic-research-the-week/ http://www.heffter.org/news/the-government-should-support-psychedelic-research-the-week/#comments Wed, 11 Feb 2015 02:33:42 +0000 http://www.heffter.org/news/?p=230 An opinion piece in the popular news magazine THE WEEK encourages government funding of scientific research into psychedelics. National correspondent Brian Cooper examines how pharmaceutical companies fund research on new drugs using two examples–psychedelics and antibiotics. In both cases, the industry has financial incentives for avoiding research. The solution, according to Cooper, is to provide an independent source of funding.

“So what is to be done? First, direct government funding is and always has been an important part of scientific funding. In a sane world, with substances as promising as the above psychedelics, the government would simply fund the research itself and be done with it. Only an increasingly anachronistic brand of drug warrior politics stands in the way. But with something like 22 veterans per day committing suicide, any treatment with a potential 60+ percent long-tem cure rate for PTSD ought to be jammed through mass trials at the highest possible speed.”

Why the government should be funding mass scientific studies of Ecstasy, magic mushrooms, and LSD | THE WEEK

http://www.heffter.org/news/the-government-should-support-psychedelic-research-the-week/feed/ 0
The Trip Treatment | The New Yorker http://www.heffter.org/news/trip-treatment-new-yorker/ http://www.heffter.org/news/trip-treatment-new-yorker/#comments Mon, 02 Feb 2015 22:47:23 +0000 http://www.heffter.org/news/?p=227 As a sign of growing public awareness and acceptance of psychedelic research, The New Yorker, possibly the nation’s most prestigious general-interest magazine, features an extensive article on the subject in its issue of February 9th, 2015. Author Michael Pollan (The Omnivore’s Dilemma) focuses on the use of psilocybin as a treatment for end-of-life anxiety in cancer patients. Pollan interviewed several Heffter-supported researchers at Johns Hopkins and New York University.

“As I chatted with Tony Bossis and Stephen Ross in the treatment room at N.Y.U., their excitement about the results was evident. According to Ross, cancer patients receiving just a single dose of psilocybin experienced immediate and dramatic reductions in anxiety and depression, improvements that were sustained for at least six months. The data are still being analyzed and have not yet been submitted to a journal for peer review, but the researchers expect to publish later this year.

“I thought the first ten or twenty people were plants ‘that they must be faking it,'” Ross told me. “They were saying things like ‘I understand love is the most powerful force on the planet,’ or ‘I had an encounter with my cancer, this black cloud of smoke.’ People who had been palpably scared of death, they lost their fear. The fact that a drug given once can have such an effect for so long is an unprecedented finding. We have never had anything like it in the psychiatric field.”

The Trip Treatment | The New Yorker

http://www.heffter.org/news/trip-treatment-new-yorker/feed/ 0
Current Drug Abuse Reviews devotes issue to psychedelics http://www.heffter.org/news/current-drug-abuse-reviews-devotes-issue-psychedelics/ http://www.heffter.org/news/current-drug-abuse-reviews-devotes-issue-psychedelics/#comments Sat, 31 Jan 2015 14:30:50 +0000 http://www.heffter.org/news/?p=226 The new issue of the journal Current Drug Abuse Reviews is devoted to psychedelic research. The issue includes articles on the use of psychedelics for treating substance abuse, crisis intervention, and the subjective experiences of psilocybin users in an fMRI study.

“We are witnessing a revival of psychedelic research. An increasing number of studies investigating the therapeutic use of psychedelics are currently underway at some of the most renowned universities. Dedicating a second issue of ‘Current Drug Abuse Reviews’ to psychedelics aims to keep up with this blossoming field. With the availability of modern scientific instruments, psychedelic research is once again gaining a firm foothold in academia.”

Current Drug Abuse Reviews Volume 7, Number 2

http://www.heffter.org/news/current-drug-abuse-reviews-devotes-issue-psychedelics/feed/ 0